» Articles » PMID: 38236835

Infection Prevention and Control Measures to Reduce the Transmission of Mpox: A Systematic Review

Overview
Specialty Public Health
Date 2024 Jan 18
PMID 38236835
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To make inferences regarding the effectiveness of respiratory interventions and case isolation measures in reducing or preventing the transmission of mpox based on synthesis of available literature.

Methods: The WHO Clinical Management and Infection Prevention and Control 2022 guideline and droplet precautions in healthcare facilities and home isolation infection prevention control measures for patients with mpox. We conducted a systematic review that included a broad search of five electronic databases. In a two-stage process, we initially sought only randomized controlled trials and observational comparative studies; when the search failed to yield eligible studies, the subsequent search included all study designs including clinical and environmental sampling studies.

Results: No studies were identified that directly addressed airborne and droplet precautions and home isolation infection prevention control measures. To inform the review questions the review team synthesized route of transmission data in mpox. There were 2366/4309 (54.9%) cases in which investigators identified mpox infection occurring following transmission through direct physical sexual contact. There were no reported mpox cases in which investigators identified inhalation as a single route of transmission. There were 2/4309 cases in which investigators identified fomite as a single route of transmission. Clinical and environmental sampling studies isolated mpox virus in a minority of saliva, oropharangeal swabs, mpox skin lesions, and hospital room air.

Conclusions: Current findings provide compelling evidence that transmission of mpox occurs through direct physical contact. Because investigators have not reported any cases of transmission via inhalation alone, the impact of airborne and droplet infection prevention control measures in reducing transmission will be minimal. Avoiding physical contact with others, covering mpox lesions and wearing a medical mask is likely to reduce onward mpox transmission; there may be minimal reduction in transmission from additionally physically isolating patients with mild disease at home.

Citing Articles

Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic.

Kumar D, Malviya R, Srivastava S, Sridhar S, Talath S, Shareef J Infect Med (Beijing). 2025; 4(1):100166.

PMID: 40060189 PMC: 11889354. DOI: 10.1016/j.imj.2025.100166.


Mpox caused by Clade Ib: Epidemiological characteristics, prevention, and control.

Du M, Liu M, Liu J Chin Med J (Engl). 2025; .

PMID: 39844015 PMC: 11882277. DOI: 10.1097/CM9.0000000000003464.


Clade Ib: a new emerging threat in the Mpox outbreak.

Srivastava S, Laxmi , Sharma K, Sridhar S, Talath S, Shareef J Front Pharmacol. 2025; 15:1504154.

PMID: 39749207 PMC: 11693458. DOI: 10.3389/fphar.2024.1504154.


Time series modelling and forecasting of Monkeypox outbreak trends Africa's in most affected countries.

Jena D, Sridhar S, Shareef J, Talath S, Ballal S, Kumar S New Microbes New Infect. 2024; 62:101526.

PMID: 39634628 PMC: 11616522. DOI: 10.1016/j.nmni.2024.101526.


First Nationwide Mpox Vaccination Program in the Republic of Korea: Implications for an Enhanced Public Health Response.

Kwon S, Song M, Lee W, Shin J, Lee S, Yeo S J Korean Med Sci. 2024; 39(32):e235.

PMID: 39164057 PMC: 11333806. DOI: 10.3346/jkms.2024.39.e235.

References
1.
Maronese C, Beretta A, Avallone G, Boggio F, Marletta D, Murgia G . Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy. Br J Dermatol. 2022; 187(5):822-823. PMC: 9804155. DOI: 10.1111/bjd.21773. View

2.
Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y . Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019; 19(8):872-879. PMC: 9628943. DOI: 10.1016/S1473-3099(19)30294-4. View

3.
Davido B, DAnglejan E, Baudoin R, Dahmane L, Chaud A, Cortier M . Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox. J Travel Med. 2022; 29(6). DOI: 10.1093/jtm/taac082. View

4.
Learned L, Reynolds M, Wassa D, Li Y, Olson V, Karem K . Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. 2005; 73(2):428-34. View

5.
Bruno G, Fabrizio C, Rodano L, Buccoliero G . Monkeypox in a 71-year-old woman. J Med Virol. 2022; 95(1):e27993. DOI: 10.1002/jmv.27993. View